In breast cancer, the expression levels of METTL14 and ALKBH5 regulate each other and together promote tumour development by regulating m6A modification levels in specific transcripts associated with epithelial-mesenchymal transition (EMT) and angiogenesis (29). Here, METTL14 is linked to neoplasm.